FOXO3-NF-κB RelA Protein Complexes Reduce Proinflammatory Cell Signaling and Function.

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Tumor-associated myeloid cells, including dendritic cells (DCs) and macrophages, often exhibit immune-suppressive functions within the tumor microenvironment.
• Understanding the molecular mechanisms that regulate myeloid cell activity is crucial for developing effective cancer immunotherapies.

Purpose of the Study:

• To elucidate a novel molecular mechanism controlling immune suppression by tumor-associated myeloid cells.
• To identify and characterize the interaction between FOXO3 and NF-κB RelA in dendritic cells.
• To explore the potential of targeting this interaction for enhancing anti-tumor immunity.

Main Methods:

• Biochemical assays to detect and characterize protein-protein interactions.
• Cytosolic and nuclear fractionation to determine protein localization.
• Site-directed mutagenesis to investigate the functional consequences of the FOXO3-NF-κB RelA interaction.

Main Results:

• A direct interaction between FOXO3 and NF-κB RelA was identified in the cytosol of tumor-associated dendritic cells.
• This interaction prevents FOXO3 degradation and inhibits NF-κB RelA nuclear translocation, thereby modulating myeloid cell signaling.
• Deletion of a specific sequence in FOXO3 containing the DNA binding domain restored NF-κB RelA activation.

Conclusions:

• A novel mechanism involving FOXO3 and NF-κB RelA interaction regulates myeloid cell immune suppression.
• This interaction represents a potential therapeutic target for enhancing anti-tumor immunity by modulating dendritic cell function.